Prestige Biologics said it has signed a contract manufacturing organization (CMO) agreement with Celltrion for the latter's clinical materials, amounting to 9 billion won ($6.6 million).This contract represents a 522 percent increase over the previous year's revenue of 1.7 billion won, quintupling t
LG Chem said Wednesday that its subsidiary AVEO Pharmaceuticals, a U.S. anti-cancer drug developer, has enrolled its first patient in the U.S. phase 3 clinical trial of ficlatuzumab, a new drug for human papillomavirus (HPV) negative head and neck cancer.AVEO Pharmaceuticals is accelerating the deve
MSD Korea highlighted the importance of biomarker pathology testing for the treatment of gastric cancer patients to improve the utilization of the anti-programmed cell death protein-1 (PD-1) immunotherapy, Keytruda (pembrolizumab), on Tuesday.Lee Hye-seung, Professor of Pathology at Seoul National U
HK inno.N said Tuesday that its CAR-T cell therapy research project has been selected by the Korea Drug Development Fund (KDDF) as a national drug development support project.CAR-T cell therapy is a treatment made by adding a chimeric antigen receptor (CAR) that can recognize specific antigens on ca
Dong-A Pharmaceutical said Monday that it has launched Vetple, a premium pet brand.Vetple provides healthcare for dogs and cats with customized pet nutrition products developed by Dong-A Pharm's veterinarians and pet experts.The new products include three products for dogs (joint care, eye care, and
Hanmi Science, the holding company of Hanmi Pharm, announced a significant restructuring, welcoming OCI Group as its major shareholder and establishing a joint management system.The move, made public on Saturday last week, was a surprise to many, including Hanmi Pharm CEO Lim Jong-yoon, who expresse
JW Pharmaceutical said Monday that it has received investigational new drug (IND) approval from the National Pharmaceutical Regulatory Agency (NPRA) of Malaysia for a phase 3 clinical trial for its gout drug candidate, URC102 (epaminurad).The phase 3 trial will evaluate the efficacy and safety of ep
S.Thepharm, an aesthetic products company that is a subsidiary of Kosdaq-listed S.Biomedics, said Monday that three of its hyaluronic acid fillers, Qtfill Signature, have received product licenses in Vietnam.Qtfill Signature consists of fillers used to improve facial wrinkles in adults through physi
The supply shortage of AstraZeneca Korea’s migraine treatment Zomig (zolmitriptan) Tab. has occurred again.According to the Ministry of Food and Drug Safety (MFDS), AstraZeneca reported a shortage of Zomig 2.5mg on Thursday. Zomig is a selective 5-HT receptor agonist and is licensed in Korea for the
Pharmgen Science said Friday that it has received approval from the Ministry of Food and Drug Safety (MFDS) for Pharmgen Covid/Flu A&B Antigen Combo, a kit for the simultaneous diagnosis of Covid-19 and influenza A and B viruses.The combo kit is a diagnostic device that detects covid-19 and influenz
ViGenCell said Thursday that a study demonstrating the world's first direct therapeutic effect on atopic dermatitis using cord blood-derived myeloid suppressor (CBMS) cells has been published in an SCI-ranked journal.The study, "Skin Repair and Immunoregulatory Effects of Myeloid Suppressor Cells fr
Daiichi Sankyo and AstraZeneca Korea's new antibody-drug conjugate (ADC) drug Enhertu 100 mg (trastuzumab deruxtecan) has been rejected by the Pharmaceutical Reimbursement Evaluation Committee.The Health Insurance Review and Assessment Service (HIRA) held this year’s first Pharmaceutical Reimburseme
Celltrion said Friday that its biosimilar products for autoimmune diseases are continuing to make an impact, winning bids in key European countries.First, Celltrion said that Yuflyma won state bids for adalimumab in Friuli-Venezia Giulia (FVG) and Sicilia, Italy, securing to provide Yuflyma for four
Ono Pharmaceutical Korea said Thursday that Braftovi (encorafenib), a targeted therapy for BRAF V600E-mutated metastatic colorectal cancer, has been approved for health insurance coverage effective Jan. 1.The reimbursement will be available in combination with cetuximab for patients with metastatic
LG Chem said Thursday that it will co-market Kyowa Kirin’s Nephoxil (ferric citrate hydrate), a hyperphosphatemia drug, for patients with chronic kidney disease undergoing hemodialysis in Korea. Hyperphosphatemia is a disorder of electrolyte metabolism caused by abnormal kidney function that can lea
Ahead of the patent expiration of anti-PD-1 inhibitor Keytruda (pembrolizumab), MSD (Merck & Co in the U.S.) is looking to secure new growth engines by developing Keytruda combination therapy and antibody-drug conjugate (ADC) pipeline.Yujin Investment & Securities analyzed MSD's stock price and pipe
Dong-A ST signed a memorandum of understanding with Eleven Therapeutics to develop RNA-based gene therapy on the sidelines of the J.P. Morgan Healthcare Conference on Tuesday (local time). The JPMHC 2024 is held in San Francisco, Calif., from Monday to Thursday.The two companies will collaborate on
Boryung said Wednesday that it has signed a sales agreement with Baxter Korea to sell inhalation anesthesia Suprane Solution and blood substitute Plasma Lyte 148 Inj 1,000ml in the domestic market.Suprane (desflurane), the original drug developed by Baxter, is a leading inhalation anesthetic used to
Ildong Pharmaceutical said Wednesday that it has signed an eye drop co-promotion agreement with Hanlim Pharm to enter the OTC (over-the-counter) market in the ophthalmology sector.The items to be co-promoted are three brands of over-the-counter eye drops -- Nazorin, Numaren, and Eyefeel -- which wil
Hyundai Pharm said Wednesday it has received approval from the Ministry of Food and Drug Safety (MFDS) for Niserin Tab 30mg (nicergoline), a brain function enhancer.Nicergoline inhibits alpha-1 adrenergic receptors, resulting in peripheral vasodilation to increase blood circulation in the brain.Nice